These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22933201)

  • 1. [Autoantibodies in systemic sclerosis].
    Genth E; Mierau R
    Dtsch Med Wochenschr; 2012 Sep; 137(36):1758-60. PubMed ID: 22933201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interstitial lung manifestations in systemic scleroderma. Correlation between alveolitis, autoantibodies and clinical manifestations].
    Witt C; Hiepe F; Brenke A; Romberg B; Apostoloff E
    Z Arztl Fortbild (Jena); 1994 Nov; 88(11):867-71. PubMed ID: 7839707
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictive value of antinuclear autoantibodies: the lessons of the systemic sclerosis autoantibodies.
    Koenig M; Dieudé M; Senécal JL
    Autoimmun Rev; 2008 Sep; 7(8):588-93. PubMed ID: 18617021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
    Mierau R; Genth E
    Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort.
    Foeldvari I; Nihtyanova SI; Wierk A; Denton CP
    J Rheumatol; 2010 Nov; 37(11):2422-6. PubMed ID: 20843905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic significance of scleroderma and myositis-associated autoantibodies].
    Genth E; Mierau R
    Z Rheumatol; 1995; 54(1):39-49. PubMed ID: 7725809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on autoantibodies in systemic sclerosis.
    Walker JG; Fritzler MJ
    Curr Opin Rheumatol; 2007 Nov; 19(6):580-91. PubMed ID: 17917539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient with systemic sclerosis, severe cytopenias and the simultaneous presence of anti-centromere and anti-SCL-70-antibodies.
    Hietarinta M; Tertti R; Lassila O
    Clin Exp Rheumatol; 1993; 11(4):457-8. PubMed ID: 8403594
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma.
    Ceribelli A; Cavazzana I; Franceschini F; Airò P; Tincani A; Cattaneo R; Pauley BA; Chan EK; Satoh M
    J Rheumatol; 2010 Oct; 37(10):2071-5. PubMed ID: 20682663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
    Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
    Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical correlations of hypocomplementaemia in systemic sclerosis: an analysis of the EULAR Scleroderma Trial and Research group (EUSTAR) database.
    Foocharoen C; Distler O; Becker M; Müller-Ladner U; von Mühlen C; Leuchten N; Walker UA
    Scand J Rheumatol; 2012 May; 41(3):243-6. PubMed ID: 22309107
    [No Abstract]   [Full Text] [Related]  

  • 16. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-U3RNP(fibrillarin) and anti-7-2RNP(Th/To) antibodies].
    Mimori T
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():565-8. PubMed ID: 20942130
    [No Abstract]   [Full Text] [Related]  

  • 18. [Systemic sclerosis. A rare connective tissue disease with manifestations in many organs].
    Haugeberg G; Brodin C; Johnsen V
    Tidsskr Nor Laegeforen; 1995 Nov; 115(29):3619-21. PubMed ID: 8539716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary biliary cirrhosis-specific autoantibodies in patients with systemic sclerosis.
    Mytilinaiou MG; Bogdanos DP
    Dig Liver Dis; 2009 Dec; 41(12):916; author reply 916-7. PubMed ID: 19604733
    [No Abstract]   [Full Text] [Related]  

  • 20. [Systemic scleroderma].
    Kolyvanos Naumann U; Kaser L; Vetter W
    Praxis (Bern 1994); 2003 Jul; 92(31-32):1295-7; quiz 1297, 1330. PubMed ID: 14740645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.